Eisai Revenue 2006-2020 | ESALY

Eisai annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Eisai revenue for the quarter ending June 30, 2020 was $1.540B, a 20.61% increase year-over-year.
  • Eisai revenue for the twelve months ending June 30, 2020 was $4.352B, a 10.6% decline year-over-year.
  • Eisai annual revenue for 2020 was $6.4B, a 10.62% increase from 2019.
  • Eisai annual revenue for 2019 was $5.786B, a 7.13% increase from 2018.
  • Eisai annual revenue for 2018 was $5.4B, a 7.72% increase from 2017.
Eisai Annual Revenue
(Millions of US $)
2020 $6,400
2019 $5,786
2018 $5,400
2017 $5,014
2016 $4,548
2015 $4,991
2014 $6,004
2013 $6,941
2012 $8,229
2011 $9,264
2010 $8,674
2009 $7,817
2008 $7,343
2007 $5,713
2006 $5,411
2005 $4,981
Eisai Quarterly Revenue
(Millions of US $)
2020-06-30 $1,540
2019-12-31
2019-06-30 $1,401
2018-06-30 $1,410
2017-06-30 $1,277
2016-06-30 $1,273
2015-06-30 $1,142
2015-03-31 $1,176
2014-12-31 $1,182
2014-09-30 $1,312
2014-06-30 $1,298
2014-03-31 $1,482
2013-12-31 $1,406
2013-09-30 $1,548
2013-06-30 $1,573
2013-03-31 $1,543
2012-12-31 $1,760
2012-09-30 $1,798
2012-06-30 $1,836
2012-03-31 $1,853
2011-12-31 $2,242
2011-09-30 $2,112
2011-06-30 $2,058
2011-03-31 $1,885
2010-12-31 $2,455
2010-09-30 $4,824
2010-06-30 $2,122
2010-03-31 $2,136
2009-12-31 $2,326
2009-09-30 $2,143
2009-06-30 $1,947
2009-03-31 $2,014
2008-12-31 $1,999
2008-09-30 $1,827
2008-06-30 $1,958
2008-03-31 $1,747
2007-12-31 $1,771
2007-09-30 $1,494
2007-06-30 $1,408
2007-03-31 $1,387
2006-12-31 $1,451
2006-09-30 $1,489
2006-06-30 $1,385
2006-03-31 $1,362
2005-12-31 $1,506
2005-09-30 $1,322
2005-06-30 $1,222
2005-03-31 $1,286
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $26.691B $6.400B
Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.063B 42.70
Takeda Pharmaceutical (TAK) Japan $58.420B 10.18
Astellas Pharma (ALPMY) Japan $28.616B 14.50
UCB SA (UCBJF) Belgium $22.660B 0.00
Merck (MKGAF) Germany $18.675B 24.49
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.291B 43.20
Grifols, S.A (GRFS) Spain $11.489B 14.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.219B 35.69
IPSEN SA ADR (IPSEY) France $8.673B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.656B 12.66
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Ionis Pharmaceuticals (IONS) United States $6.795B 43.04
Arrowhead Pharmaceuticals (ARWR) United States $4.533B 0.00
United Therapeutics (UTHR) United States $4.437B 10.26
Evotec AG (EVTCY) Germany $4.033B 140.00
FibroGen (FGEN) United States $3.866B 0.00
Hypermarcas (HYPMY) Brazil $3.572B 13.14
ChemoCentryx (CCXI) United States $3.562B 0.00
Nektar Therapeutics (NKTR) United States $3.226B 0.00
PTC Therapeutics (PTCT) United States $3.140B 0.00
Sage Therapeutics (SAGE) United States $3.061B 0.00
Pacira BioSciences (PCRX) United States $2.438B 64.10
Xencor (XNCR) United States $2.124B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.112B 10.22
Revolution Medicines (RVMD) United States $2.071B 0.00
Corcept Therapeutics (CORT) United States $1.938B 17.85
Cronos Group (CRON) Canada $1.795B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.773B 0.00
USANA Health Sciences (USNA) United States $1.558B 14.68
Ironwood Pharmaceuticals (IRWD) United States $1.513B 10.51
Trillium Therapeutics (TRIL) Canada $1.340B 0.00
Heron Therapeutics (HRTX) United States $1.324B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.145B 10.91
Indivior (INVVY) United States $1.124B 13.93
Karyopharm Therapeutics (KPTI) United States $1.080B 0.00
Esperion Therapeutics (ESPR) United States $1.003B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.993B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Zogenix (ZGNX) United States $0.985B 0.00
Translate Bio (TBIO) United States $0.938B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.872B 543.00
VAXART, INC (VXRT) United States $0.752B 0.00
Endo (ENDP) Ireland $0.694B 1.03
Spectrum Pharmaceuticals (SPPI) United States $0.616B 0.00
Collegium Pharmaceutical (COLL) United States $0.614B 0.00
ImmunoGen (IMGN) United States $0.611B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.606B 0.00
Tilray (TLRY) Canada $0.604B 0.00
Siga Technologies (SIGA) United States $0.547B 58.33
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Aerie Pharmaceuticals (AERI) United States $0.541B 0.00
Flexion Therapeutics (FLXN) United States $0.519B 0.00
Radius Health (RDUS) United States $0.507B 0.00
Molecular Templates (MTEM) United States $0.505B 0.00
Ocular Therapeutix (OCUL) United States $0.492B 0.00
Ardelyx (ARDX) United States $0.474B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Altimmune (ALT) United States $0.396B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.385B 19.19
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
TherapeuticsMD (TXMD) United States $0.357B 0.00
Akebia Therapeutics (AKBA) United States $0.353B 0.00
Redhill Biopharma (RDHL) Israel $0.352B 0.00
MEI Pharma (MEIP) United States $0.340B 0.00
DURECT (DRRX) United States $0.331B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.318B 7.88
PROFOUND MEDICL (PROF) Canada $0.317B 0.00
IMV INC (IMV) Canada $0.295B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
Menlo Therapeutics (VYNE) United States $0.272B 0.00
Jounce Therapeutics (JNCE) United States $0.269B 12.73
Aquestive Therapeutics (AQST) United States $0.262B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Rafael Holdings (RFL) United States $0.253B 0.00
Calithera Biosciences (CALA) United States $0.240B 0.00
Lannett Co Inc (LCI) United States $0.234B 5.44
KalVista Pharmaceuticals (KALV) United States $0.228B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.220B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.04
Avadel Pharmaceuticals (AVDL) Ireland $0.188B 0.00
CASI Pharmaceuticals (CASI) United States $0.187B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
Nivalis Therapeutics (ALPN) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
OptiNose (OPTN) United States $0.174B 0.00
Otonomy (OTIC) United States $0.170B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.126B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.105B 0.00
Aclaris Therapeutics (ACRS) United States $0.103B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
Biomerica (BMRA) United States $0.078B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
CTI BioPharma (CTIC) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Novan (NOVN) United States $0.067B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
CV Sciences (CVSI) United States $0.052B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
KemPharm (KMPH) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.82
India Globalization Capital (IGC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
IsoRay (ISR) United States $0.037B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.036B 0.00
GTx (ONCT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.81
Opiant Pharmaceuticals (OPNT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
AgeX Therapeutics (AGE) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Vical (BBI) United States $0.022B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.015B 23.27
Flex Pharma (SLRX) United States $0.015B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00